Smith+Nephew introduced the WEREWOLF FASTSEAL 6.0 Hemostasis Wand, bringing its leading radiofrequency technology to orthopedic reconstruction surgeons.
Using low temperature thermal energy, the FASTSEAL 6.0 Hemostasis Wand delivers hemostatic sealing during open orthopedic procedures such as total joint arthroplasty. This technology has shown to significantly reduce total blood loss as well as significantly shortening procedure time.
Intra-operative bleeding presents challenges for surgeons, including risks to patients and impaired visibility during the procedure. The FASTSEAL 6.0 Wand aims to support surgeons to overcome those challenges while managing patient outcomes.
The launch of the FASTSEAL 6.0 Wand expands the WEREWOLF platform using Smith+Nephew's radiofrequency technology. Building off the legacy of the WEREWOLF brand, predominantly used in Sports Medicine and Ear, Nose and Throat procedures, the latest generation of the WEREWOLF Controller now allows for one single system to be used across multiple specialties.
"We're thrilled to introduce our industry-leading WEREWOLF technology into a new market segment with hemostasis wands," said Scott Schaffner, SVP and GM, Global Sports Medicine, Smith+Nephew. "With this launch we're combining our most innovative Sports Medicine technology with our leading Orthopaedic Reconstruction portfolio to offer a complete Smith+Nephew solution; one that is hugely valuable for our orthopaedic customers and their patients."